EZZ
EZZ Life Science Holdings Ltd
- Announcements, last 12 months
- 26
- Price sensitive, last 12 months
- 9
- Followed on InvestorPA
- Some (Among the 20% most-followed companies on InvestorPA)
Latest announcements
| Released | Headline | Actions |
|---|---|---|
| Change of Director's Interest Notice | ||
| EZZ Corporate Governance Statement and Appendix 4G | ||
| Annual Report to shareholders | ||
| Preliminary Final Report Price sensitive | AI summary | |
| Quarterly Activity and Cashflow Report Price sensitive | AI summary | |
| Quarterly Activity and Cashflow Report Price sensitive | AI summary | |
| Half Yearly Report and Accounts Price sensitive | AI summary | |
| EZZ Appoints Aumake in $10m Exclusive Distributor Agreement Price sensitive | AI summary | |
| $10m Exclusive Distribution Agreement with EZZ Life Sciences Price sensitive | AI summary | |
| Quarterly Activities/Appendix 4C Cashflow Report Price sensitive | AI summary |
Sign in to see all EZZ announcements.
Guidance history
| 31 Jul 2026 | Customer receipts $9.8m, operating cash outflow $0.05m, cash and cash equivalents $9.7m | |
| 17 Feb 2026 | The agreement sets out minimum sales targets of $2.5m per year each year for four years, totaling $10 million Australian dollars for the product range. | |
| 30 Oct 2025 | The company expects higher sales in Q2 ahead of the 11.11 Shopping Festival. |
Sign in to see the full guidance history.
Most followed in Health Care
Follow EZZ to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.
Sign in